Sunniva Inc. to delay earnings release until April 30, 2018
VANCOUVER, BC – April 24, 2018 – Sunniva Inc. (“Sunniva” or the “Company“) (CSE:SNN) (OTCQX:SNNVF) announced today that it will delay its fourth quarter and year ended December 31, 2017 earnings release and the subsequent earnings call, previously scheduled for April 24, 2018 and April 25, 2018, respectively. The Company now intends to release its results on April 30, 2018, after markets close. The delay is required for the Company’s auditors to complete their final audit procedures.
The Company’s executive management will discuss the results during the rescheduled conference call on Tuesday, May 1, 2018 at 11:30 am Eastern Time/8:30 am Pacific Time. To participate in the call, please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674- 8052 and entering access code 5312. The replay will be available for two weeks after the call.
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.
For more information please visit: www.sunniva.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Dr. Anthony Holler
Chairman and Chief Executive Officer
Investor Relations Contact:
Manager, Investor Relations